Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Change in Inventory (2016 - 2025)

United Therapeutics' Change in Inventory history spans 17 years, with the latest figure at $16.5 million for Q4 2025.

  • For Q4 2025, Change in Inventory rose 42.24% year-over-year to $16.5 million; the TTM value through Dec 2025 reached $52.6 million, up 12.15%, while the annual FY2025 figure was $52.6 million, 12.15% up from the prior year.
  • Change in Inventory for Q4 2025 was $16.5 million at United Therapeutics, down from $17.5 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $17.5 million in Q3 2025 and bottomed at -$5.7 million in Q1 2022.
  • The 5-year median for Change in Inventory is $7.2 million (2023), against an average of $6.7 million.
  • The largest YoY upside for Change in Inventory was 13800.0% in 2022 against a maximum downside of 359.09% in 2022.
  • A 5-year view of Change in Inventory shows it stood at $100000.0 in 2021, then surged by 13800.0% to $13.9 million in 2022, then plummeted by 49.64% to $7.0 million in 2023, then soared by 65.71% to $11.6 million in 2024, then surged by 42.24% to $16.5 million in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Change in Inventory are $16.5 million (Q4 2025), $17.5 million (Q3 2025), and $7.4 million (Q2 2025).